Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Minoxidil and oral antioxidants helped improve hair growth in a patient with hair loss due to lupus.

Wedelolactone selectively kills prostate cancer cells without harming normal cells.

Alpha-tocopherol does not prevent hair loss from doxorubicin.

Tralokinumab effectively improved atopic dermatitis symptoms in most patients, but some stopped due to side effects like hair loss.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

CS12192 effectively treats alopecia areata with better safety than current options.

The gene therapy showed significant wound healing and was safe for treating severe RDEB.

Ritlecitinib works well and is safe for treating alopecia areata.

Sonidegib effectively treated basal cell carcinoma in a patient with lupus without worsening lupus symptoms.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Certain cancer drugs can cause skin issues like rashes and itching.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

JAK inhibitors help regrow hair in alopecia areata, but their long-term safety is still unclear.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

A woman with severe angioedema improved significantly after treatment with rituximab.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

ZD1839 (Iressa) causes skin and hair side effects, treatable with tretinoin cream and minocycline.

The combined treatment of Finasteride and Doxazosin affects prostate tissue by reducing cell growth and altering hormone levels.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.